Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when PGNY files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsProgyny authorizes up to $200M share buyback program funded by cash on hand
Filed May 26, 2026 · Period ending May 26, 2026 · ~1 min read
Key Changes
-
high
Board approved up to $200 million in share repurchases using existing cash, signaling management believes stock may be undervalued and prioritizing shareholder returns over other capital uses.
Item 8.01 verify on EDGAR → -
medium
Repurchases will occur at management's discretion through open market purchases or 10b5-1 plans, with timing dependent on stock price and market conditions. Program can be suspended or ended at any time.
Item 8.01 verify on EDGAR →
Summary
Progyny announced its Board has authorized a share repurchase program of up to $200 million, to be funded from the company's existing cash reserves. This capital allocation decision suggests management views the current stock price as attractive and represents a shift toward returning capital to shareholders rather than deploying cash for operational expansion or acquisitions.
The authorization provides a ceiling rather than a commitment—actual buybacks will depend entirely on management's assessment of market conditions, stock price, and competing uses for capital. For retail investors, this is generally a positive signal about management's confidence in the business and cash generation.
However, the discretionary nature means there's no guarantee the full up to $200 million will be deployed. Watch for quarterly disclosures of actual repurchase activity and any commentary on cash deployment strategy in upcoming earnings calls. The effectiveness of the program will depend on execution timing and price levels achieved.
Section-by-Section Diff
Event · Item 8.01 — Other Events
Progyny announced a up to $200 million share repurchase program funded by cash, with timing and amount at management's discretion.
Added in current filing · verify on EDGAR →
Progyny, Inc. (the “Company”) announced today that its Board of Directors has approved a share repurchase program to repurchase up to $200 million of its common stock. The program will be funded through available cash balances.
The Board authorized a new $200 million share repurchase program to be funded from existing cash. This signals management's view that the stock may be undervalued and represents a capital allocation decision to return cash to shareholders rather than invest in operations or acquisitions.
Added in current filing · verify on EDGAR →
Shares may be repurchased through open market repurchases, including through plans complying with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, depending on stock price, market conditions and other factors deemed relevant in the Company’s sole discretion. The program may be suspended or discontinued at any time.
The company retains full discretion over timing, pricing, and execution of buybacks, including the ability to suspend or terminate the program. This means the $200 million authorization is a ceiling, not a commitment, and actual repurchases will depend on management's assessment of market conditions and alternative uses of capital.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · May 28, 2026 · How we verify